Paradigm Biopharmaceuticals Ltd. (AU:PAR) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Paradigm Biopharmaceuticals Ltd. has announced a proposed issuance of 2.9 million unlisted performance rights with a three-year expiry, set for December 16, 2024. This move could potentially influence the company’s stock dynamics as investors anticipate the impact of these new securities. The announcement comes as the company aims to strengthen its financial strategy and market position.
For further insights into AU:PAR stock, check out TipRanks’ Stock Analysis page.
